Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 15/20 | 1.00 |
| ▸ | PDK1 | Q15118 | 1/20 | 1.00 |
| ▸ | HTR7 | P34969 | 1/20 | 0.48 |
| ▸ | FDPS | P14324 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28079135 | 0.89 | FBP1 (0.80) | FBP1PDK1HTR7FDPSALDH1A1 | |
| SCHEMBL11829207 | 0.88 | FBP1 (0.81) | FBP1PDK1HTR7FDPSALDH1A1 | |
| SCHEMBL11824120 | 0.88 | FBP1 (0.77) | FBP1PDK1HTR7FDPSALDH1A1 | |
| SCHEMBL28382830 | 0.87 | FBP1 (0.76) | FBP1PDK1HTR7FDPSALDH1A1 | |
| SCHEMBL8371244 | 0.85 | — | — | |
| SCHEMBL11445382 | 0.85 | — | — | |
| SCHEMBL9731968 | 0.85 | — | — | |
| SCHEMBL11818034 | 0.83 | FBP1 (0.70) | FBP1PDK1HTR7FDPSALDH1A1 | |
| SCHEMBL11819066 | 0.83 | FBP1 (0.70) | FBP1PDK1HTR7FDPSALDH1A1 | |
| SCHEMBL11824652 | 0.82 | FBP1 (0.73) | FBP1PDK1HTR7FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3789447-B1 | CROSSLINKING AGENTS FOR POLYMERIC SYSTEMS | HENKEL AG & CO KGAA (DE) | 2025-09-03 | — | — | EP | claimed |
| CN-114341260-B | Cross-linking agents for polymer systems | 汉高股份有限及两合公司 | 2024-11-19 | — | — | CN | claimed |
| US-20220162401-A1 | CROSSLINKING AGENTS FOR POLYMERIC SYSTEMS | HENKEL AG & CO KGAA (DE) | 2022-05-26 | — | — | US | claimed |
| CN-114341260-A | Crosslinking agents for polymer systems | 汉高股份有限及两合公司 | 2022-04-12 | — | — | CN | claimed |
| WO-2021043800-A1 | CROSSLINKING AGENTS FOR POLYMERIC SYSTEMS | HENKEL AG & CO. KGAA (DE) | 2021-03-11 | — | — | WO | claimed |
| US-10758569-B2 | Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin | THE GENERAL HOSPITAL CORPORATION (US) | 2020-09-01 | — | — | US | claimed |
| EP-3626707-A1 | HETEROARYL DISULFIDE COMPOUNDS AS ALLOSTERIC EFFECTORS FOR INCREASING THE OXYGEN-BINDING AFFINITY OF HEMOGLOBIN | The General Hospital Corporation (US) | 2020-03-25 | — | — | EP | claimed |
| EP-3094619-B1 | HETEROARYL DISULFIDE COMPOUNDS AS ALLOSTERIC EFFECTORS FOR INCREASING THE OXYGEN-BINDING AFFINITY OF HEMOGLOBIN | MASSACHUSETTS GEN HOSPITAL (US) | 2019-07-31 | — | — | EP | claimed |
| US-20160331782-A1 | HETEROARYL DISULFIDE COMPOUNDS AS ALLOSTERIC EFFECTORS FOR INCREASING THE OXYGEN-BINDING AFFINITY OF HEMOGLOBIN | THE GENERAL HOSPITAL CORPORATION | 2016-11-17 | — | — | US | claimed |
| US-8562927-B2 | Absorbent solution containing a breakdown inhibitor derived from thiazole or from oxazole and absorption process for acid compounds contained in a gaseous effluent | IFP (FR) | 2013-10-22 | — | — | US | claimed |
| US-20040072089-A1 | Toner and process for producing toner | ZEON CORPORATION (JP) | 2004-04-15 | — | — | US | claimed |
| US-20030176512-A1 | Asymmetric disulfides and methods of using same | PROLX PHARMACEUTICALS CORPORATION (CA) | 2003-09-18 | — | — | US | claimed |
| US-20030176072-A1 | Polishing compositions for noble metals | WANG HONGYU (US) | 2003-09-18 | — | — | US | claimed |
| EP-1252248-A1 | POLISHING COMPOSITIONS FOR NOBLE METALS | Rodel Holdings, Inc. (US) | 2002-10-30 | — | — | EP | claimed |
| US-20020111027-A1 | Polishing compositions for noble metals | RODEL HOLDINGS, INC. | 2002-08-15 | — | — | US | claimed |
| US-20020039839-A1 | Polishing compositions for noble metals | RODEL HOLDINGS, INC. | 2002-04-04 | — | — | US | claimed |
| WO-2001044396-A1 | POLISHING COMPOSITIONS FOR NOBLE METALS | RODEL HOLDINGS, INC. (US) | 2001-06-21 | — | — | WO | claimed |
| EP-0247888-A1 | Cross-linking halogen-containing polymers | HERCULES INCORPORATED (US) | 1987-12-02 | — | — | EP | claimed |
| US-4138346-A | ETHOXYLATED PHOSPHATE ESTER WITH A MERCAPTOTHIAZOLE, A DITHIOBIS-THIAZOLE, A SULFIDE, A DISULFIDE OR A SULFONE | BASF WYANDOTTE CORPORATION (US) | 1979-02-06 | — | — | US | claimed |
| US-3933658-A | PHOSPHATE ESTER AND SULFUR COMPOUND | GAF CORPORATION (US) | 1976-01-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160331782-A1 | HETEROARYL DISULFIDE COMPOUNDS AS ALLOSTERIC EFFECTORS FOR INCREASING THE OXYGEN-BINDING AFFINITY OF HEMOGLOBIN | HIF1AN, HBG2, HIF1A | FBP1 1435/4885PDK1 1062/4885HTR7 3073/4885 |
| US-20030176512-A1 | Asymmetric disulfides and methods of using same | PRDX3, PDIA5, PRDX5 | FBP1 2532/4885PDK1 2344/4885HTR7 4729/4885 |
| US-10758569-B2 | Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin | HIF1AN, HBG2, HIF1A | FBP1 1435/4885PDK1 1062/4885HTR7 3073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.